• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE confirms Serviscope acquisition, but is quiet on details of purchase

Article

Competition tightens as more independent firms sellGE Medical Systems confirmed that it has acquired independent service organization Serviscope of Wallingford, CT, but the Milwaukee vendor declined to provide details on the sale other than to

Competition tightens as more independent firms sell

GE Medical Systems confirmed that it has acquired independent service organization Serviscope of Wallingford, CT, but the Milwaukee vendor declined to provide details on the sale other than to acknowledge that the deal closed on Sept. 2. GE's reticence to discuss the purchase could be related to concern about the growing dominance of OEM providers in the equipment maintenance market.

Rumors of the acquisition first surfaced in September, in the form of court documents filed by an ISO industry group opposed to GE's purchase of another ISO, InnoServ Technologies of Arlington, TX (SCAN 9/30/98). The industry group, the Service Industry Association (formerly Independent Service Network International), claimed that the acquisitions would reduce competition in the service market, but GE got the go-ahead to close the InnoServ deal in July after announcing a settlement with the U.S. Department of Justice.

Some market watchers believe that ISOs like InnoServ and Serviscope are choosing to sell out to OEMs because of the extensive resources required to offer multivendor service and asset management. As hospitals seek the convenience that multivendor service can provide, smaller firms struggle to pay for the service expertise and spare parts necessary to maintain equipment models from a range of vendors.

Large OEMs have more resources to offer multivendor programs, but the result of the recent acquisition spree is fewer choices and less competition for service, according to Ron Katz, an attorney with Coudert Brothers in San Francisco and general counsel to the Service Industry Association. Katz believes that GE's behavior not only hurts ISOs by making it difficult for them to compete, but also hurts other OEMs by reducing the pool of partners for multivendor service.

"The fact that there is multivendor service should help ISOs, because the OEMs usually have to subcontract from ISOs to get that multivendor service," Katz said. "What's making it difficult (for ISOs to survive) is GE's monopolizing conduct."

Due to ISO consolidation, there are few other large independent companies left on the multivendor service landscape. One of these firms is COHR of Chatsworth, CA, which is beginning to stabilize its business after suffering a string of legal and financial difficulties earlier in the year. GE's recent acquisitions should prove beneficial to COHR, as the company is one of the few remaining alternatives to OEM service, according to Raymond List, president and CEO.

"We think this is a huge opportunity, because there's a substantial market position for a large national independent ISO," List said. "We believe there's a good situation out there."

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.